Items where authors include "Koster, L."

Article

Garderet, L. orcid.org/0000-0002-6138-8112, Gras, L., Koster, L. et al. (43 more authors) (2024) Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: a study of the worldwide network for blood and marrow transplantation (WBMT). American Journal of Hematology, 99 (11). pp. 2084-2095. ISSN 0361-8609

Garderet, L., Gras, L., Koster, L. et al. (23 more authors) (2024) Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Haematologica, 109 (8). ISSN 0390-6078

Scheid, C. orcid.org/0009-0007-6539-226X, Eikema, D.-J., van Gelder, M. orcid.org/0000-0001-8698-4351 et al. (27 more authors) (2024) Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? Blood, 144 (4). pp. 445-456. ISSN 0006-4971

Robin, M. orcid.org/0000-0003-1388-9876, Iacobelli, S., Koster, L. et al. (22 more authors) (2024) Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 59 (7). pp. 928-935. ISSN 0268-3369

Gurnari, C. orcid.org/0000-0001-6829-5544, Koster, L., Baaij, L.G.A. et al. (30 more authors) (2024) Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood Advances, 8 (6). pp. 1444-1448. ISSN 2473-9529

Styczynski, J. orcid.org/0000-0002-3158-119X, Tridello, G., Koster, L. et al. (25 more authors) (2023) Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT. Bone Marrow Transplantation, 58 (8). pp. 881-892. ISSN 0268-3369

Chalandon, Y. orcid.org/0000-0001-9341-8104, Sbianchi, G., Gras, L. et al. (22 more authors) (2023) Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the chronic malignancies working party of the EBMT. American Journal of Hematology, 98 (1). pp. 112-121. ISSN 0361-8609

Gagelmann, N., Eikema, D.-J., Iacobelli, S. et al. (21 more authors) (2018) Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT. Haematologica, 103 (5). pp. 890-897. ISSN 0390-6078

Proceedings Paper

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic Hematopoietic Cell Transplantation for Vexas Syndrome: Results of a Multicenter Study from the Chronic Malignancies and Autoimmune Disease Working Parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 708-710.

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic hematopoietic cell transplantation for Vexas syndrome: results of a multicenter study from the chronic malignancies and autoimmune disease working parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 708.

Mizuno, S., Gras, L., Baaij, L. et al. (42 more authors) (2023) Impact of age on outcome in newly diagnosed multiple myeloma patients undergoing upfront autologous hematopoietic cell transplantation from the worldwide network for blood and marrow transplantation global study. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California. American Society of Hematology , p. 785.

Garderet, L., Gras, L., Koster, L. et al. (22 more authors) (2023) Long term outcomes and renal response following autologous stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Cmwp of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California. American Society of Hematology , p. 3403.

Robin, M., Iacobelli, S., Passweg, J.R. et al. (22 more authors) (2023) Treosulfan compared to Busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the chronic malignancies working party of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 473.

Garderet, L., Gras, L., Koster, L. et al. (22 more authors) (2023) P478: Long term outcomes following autologous stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the CMWP of the EBMT. In: Bone Marrow Transplant. 49th Annual Meeting of the European Society for Blood and Marrow Transplantation, 23-26 Apr 2023, Paris Hybrid Meeting. Springer Nature , p. 478.